Literature DB >> 21882258

Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant mice.

Karin Heby-Henricson1, Asa Bergström, Björn Rozell, Rune Toftgård, Stephan Teglund.   

Abstract

Basal cell carcinoma of the skin typically carries genetic alterations in components of the hedgehog (HH) signaling pathway. Previously, we generated a knockout mouse with a loss-of-function mutation in suppressor of fused (Sufu), an essential repressor of the pathway downstream of Hh ligand cell surface reception. Mice heterozygous for the mutated Sufu allele develop a skin phenotype that includes lesions similar to basaloid follicular hamartomas. The purpose of the current study was to test the possibility that the simultaneous loss of the tumor suppressor gene, transformation related protein 53 (Trp53), would aggravate the Sufu skin phenotype since Trp53 loss is known to enhance the growth of other Hh-driven tumors. Consistent with previous reports, medulloblastomas and rhabdomyosarcomas developed in Sufu(+/-) ;Trp53(-/-) mice. However, the characteristic Sufu(+/-) skin phenotype was not altered in the absence of Trp53, and showed no changes in latency, multiplicity, cellular phenotype, or proliferative capacity of the basaloid lesions. This finding was both novel and intriguing and demonstrated a differential, tissue-specific sensitivity to Sufu and Trp53 tumor suppressor gene loss, which may be linked to developmental stage and the degree of proliferative activity in specific cell types.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882258      PMCID: PMC3235237          DOI: 10.1002/mc.20852

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  35 in total

1.  Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations.

Authors:  Marina Grachtchouk; Joanna Pero; Steven H Yang; Alexandre N Ermilov; L Evan Michael; Aiqin Wang; Dawn Wilbert; Rajiv M Patel; Jennifer Ferris; James Diener; Mary Allen; Seokchun Lim; Li-Jyun Syu; Monique Verhaegen; Andrzej A Dlugosz
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

2.  PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer.

Authors:  G Ling; A Ahmadian; A Persson; A B Undén; G Afink; C Williams; M Uhlén; R Toftgård; J Lundeberg; F Pontén
Journal:  Oncogene       Date:  2001-11-22       Impact factor: 9.867

3.  Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice.

Authors:  M Aszterbaum; J Epstein; A Oro; V Douglas; P E LeBoit; M P Scott; E H Epstein
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

4.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

5.  Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.

Authors:  C Wetmore; D E Eberhart; T Curran
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

6.  In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.

Authors:  M Harvey; A T Sands; R S Weiss; M E Hegi; R W Wiseman; P Pantazis; B C Giovanella; M A Tainsky; A Bradley; L A Donehower
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

7.  The magnitude of hedgehog signaling activity defines skin tumor phenotype.

Authors:  Vladimir Grachtchouk; Marina Grachtchouk; Lori Lowe; Tim Johnson; Lebing Wei; Aiqin Wang; Fred de Sauvage; Andrzej A Dlugosz
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

8.  Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.

Authors:  Mariateresa Mancuso; Simonetta Pazzaglia; Mirella Tanori; Heidi Hahn; Paola Merola; Simonetta Rebessi; Michael J Atkinson; Vincenzo Di Majo; Vincenzo Covelli; Anna Saran
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  Generation and characterization of p53 mutant mice.

Authors:  Melissa L Dumble; Lawrence A Donehower; Xiongbin Lu
Journal:  Methods Mol Biol       Date:  2003

10.  Sequences 5' of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development.

Authors:  A Ramírez; A Bravo; J L Jorcano; M Vidal
Journal:  Differentiation       Date:  1994-11       Impact factor: 3.880

View more
  5 in total

Review 1.  Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway.

Authors:  Dengliang Huang; Yiting Wang; Jiabin Tang; Shiwen Luo
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

2.  Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome.

Authors:  Kirsty Mann; Jill Magee; Marine Guillaud-Bataille; Christophe Blondel; Brigitte Bressac-de Paillerets; Josie Yeatman; Ingrid Winship
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

3.  Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications.

Authors:  Philip R Cohen; Razelle Kurzrock
Journal:  Dermatol Ther (Heidelb)       Date:  2015-04-15

4.  Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features.

Authors:  Yasuyuki Shimada; Ken-ichi Katsube; Yuji Kabasawa; Kei-ichi Morita; Ken Omura; Akira Yamaguchi; Kei Sakamoto
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

5.  Positive feedback of SuFu negating protein 1 on Hedgehog signaling promotes colorectal tumor growth.

Authors:  Zhengwei Yan; Minzhang Cheng; Guohui Hu; Yao Wang; Shaopeng Zeng; Aidi Huang; Linlin Xu; Yuan Liu; Chao Shi; Libin Deng; Quqin Lu; Hai Rao; Hua Lu; Ye-Guang Chen; Shiwen Luo
Journal:  Cell Death Dis       Date:  2021-02-19       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.